Abstract
Nonheme iron enzymes utilize S = 2 iron(IV)-oxo intermediates as oxidants in biological oxygenations. In contrast, corresponding synthetic nonheme FeIV═O complexes characterized to date favor the S = 1 ground state that generally shows much poorer oxidative reactivity than their S = 2 counterparts. However, one intriguing exception found by Nam a decade ago is the S = 1 [FeIV(O)(Me3NTB)]2+ complex (Me3NTB = [tris((N-methyl-benzimidazol-2-yl)methyl)amine], 1O) with a hydrogen atom transfer (HAT) reactivity that is 70% that of the S = 2 [FeIV(O)(TQA)]2+ complex (TQA = tris(2-quinolylmethyl)amine, 3O). In our efforts to further explore this direction, we have unexpectedly uncovered a family of new S = 1 complexes with HAT reaction rates beyond the currently reported limits in the tripodal ligand family, surpassing oxidation rates found for the S = 2 [FeIV(O)(TQA)]2+ complex by as much as an order of magnitude. This is achieved simply by replacing the secondary sphere methyl groups of the Me3NTB ligand with larger cycloalkyl-CH2 (R groups in 2OR) moieties ranging from c-propylmethyl to c-hexylmethyl. These 2OR complexes show Mössbauer data at 4 K and 1H NMR spectra at 193 and 233 K that reveal S = 1 ground states, in line with DFT calculations. Nevertheless, they give rise to the most reactive synthetic nonheme oxoiron(IV) complexes found to date within the tripodal ligand family. Our DFT study indicates transition state stabilization through entropy effects, similar to enzymatic catalysis.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.